Nicholas Haberli
Hospital Resident
Nicholas has investigated the adverse event profile of ocrelizumab (Ocrevus©) in patients with MS. He has also studied the correlation between the levels of a protein biomarker (prestin) in serum and the amount of sensorineural hearing loss in mice. He has been a teacher for first-year students in the Fundamentals of Clinical Practice course and is a member of the committee for undergraduate medical education at his school. he has served as Chair of the academic integrity honor board, SIGN vice president, and a variety of other leadership roles. He enjoys Dungeons and Dragons, movies (recently working his way through the Martin Scorsese filmography), advocacy, hiking, and travel.
Undergrad: Northeastern University
Medical School: University of Connecticut